Lee Kingston

976 total citations
34 papers, 525 citations indexed

About

Lee Kingston is a scholar working on Pharmaceutical Science, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Lee Kingston has authored 34 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmaceutical Science, 14 papers in Molecular Biology and 13 papers in Organic Chemistry. Recurrent topics in Lee Kingston's work include Chemical Reactions and Isotopes (23 papers), Asymmetric Hydrogenation and Catalysis (7 papers) and Chemical Synthesis and Analysis (6 papers). Lee Kingston is often cited by papers focused on Chemical Reactions and Isotopes (23 papers), Asymmetric Hydrogenation and Catalysis (7 papers) and Chemical Synthesis and Analysis (6 papers). Lee Kingston collaborates with scholars based in United Kingdom, Sweden and United States. Lee Kingston's co-authors include David J. Wilkinson, W. J. S. Lockley, Charles S. Elmore, John R. Jones, Magnus Schou, Edward Spink, Davide Audisio, J. R. Jones, Troels Skrydstrup and Cecilia Ericsson and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Controlled Release and The Journal of Organic Chemistry.

In The Last Decade

Lee Kingston

33 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lee Kingston United Kingdom 12 361 202 187 125 58 34 525
W. Neil Palmer United States 6 167 0.5× 522 2.6× 289 1.5× 91 0.7× 15 0.3× 6 667
Gianluca Destro United Kingdom 12 184 0.5× 91 0.5× 56 0.3× 66 0.5× 35 0.6× 18 359
Laura C. Paterson United Kingdom 9 253 0.7× 178 0.9× 194 1.0× 80 0.6× 27 0.5× 19 398
Antonio Del Vecchio France 15 133 0.4× 325 1.6× 83 0.4× 91 0.7× 26 0.4× 32 592
Andrew J. Hoover United States 6 415 1.1× 415 2.1× 334 1.8× 125 1.0× 43 0.7× 8 786
Remo Weck Germany 14 601 1.7× 168 0.8× 384 2.1× 141 1.1× 63 1.1× 23 666
Karoline T. Neumann Denmark 14 179 0.5× 520 2.6× 206 1.1× 88 0.7× 22 0.4× 23 669
Zhanghua Gao China 12 211 0.6× 347 1.7× 116 0.6× 199 1.6× 16 0.3× 38 548
Hengzhao Li China 13 212 0.6× 228 1.1× 212 1.1× 76 0.6× 16 0.3× 27 413
Anna Homs Spain 11 170 0.5× 1.1k 5.4× 320 1.7× 134 1.1× 23 0.4× 14 1.2k

Countries citing papers authored by Lee Kingston

Since Specialization
Citations

This map shows the geographic impact of Lee Kingston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Kingston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Kingston more than expected).

Fields of papers citing papers by Lee Kingston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Kingston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Kingston. The network helps show where Lee Kingston may publish in the future.

Co-authorship network of co-authors of Lee Kingston

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Kingston. A scholar is included among the top collaborators of Lee Kingston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Kingston. Lee Kingston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stéen, E. Johanna L., Lee Kingston, Nikolett Lénárt, et al.. (2025). Characterization of [3H]AZ12464237 as a high affinity, non-nucleotide antagonist radioligand for the P2Y12 receptor. Biochemical Pharmacology. 237. 116900–116900. 4 indexed citations
2.
Gómez‐Vallejo, Vanessa, Ainara Vallejo‐Illarramendi, Pablo Aguiar, et al.. (2023). Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders. Biomedicines. 11(2). 253–253. 2 indexed citations
3.
Feeney, Orlagh M., Ka Fung Noi, Dharmini Mehta, et al.. (2022). Subcutaneous delivery of a dendrimer-BH3 mimetic improves lymphatic uptake and survival in lymphoma. Journal of Controlled Release. 348. 420–430. 10 indexed citations
4.
Destro, Gianluca, Olivier Loreau, David‐Alexandre Buisson, et al.. (2020). Transition‐Metal‐Free Carbon Isotope Exchange of Phenyl Acetic Acids. Angewandte Chemie International Edition. 59(32). 13490–13495. 52 indexed citations
5.
Destro, Gianluca, Olivier Loreau, David‐Alexandre Buisson, et al.. (2020). Transition‐Metal‐Free Carbon Isotope Exchange of Phenyl Acetic Acids. Angewandte Chemie. 132(32). 13592–13597. 4 indexed citations
6.
Kingston, Lee, et al.. (2020). The synthesis of one H‐2 labeled and two H‐3 labeled leukotriene C4 synthase inhibitors. Journal of Labelled Compounds and Radiopharmaceuticals. 63(10). 434–441. 2 indexed citations
7.
Neumann, Karoline T., et al.. (2020). Direct Access to Isotopically Labeled Aliphatic Ketones Mediated by Nickel(I) Activation. Angewandte Chemie International Edition. 59(21). 8099–8103. 41 indexed citations
8.
Varnäs, Katarina, Zsolt Cselényi, Ryosuke Arakawa, et al.. (2019). The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans. Neuropharmacology. 162. 107809–107809. 11 indexed citations
9.
Bergman, Joakim, Cecilia Ericsson, Lee Kingston, et al.. (2019). Visible-Light-Enabled Aminocarbonylation of Unactivated Alkyl Iodides with Stoichiometric Carbon Monoxide for Application on Late-Stage Carbon Isotope Labeling. The Journal of Organic Chemistry. 84(24). 16076–16085. 32 indexed citations
10.
Johnström, Peter, Ram Kumar Selvaraju, Marie Svedberg, et al.. (2018). The development of a GPR44 targeting radioligand [11C]AZ12204657 for in vivo assessment of beta cell mass. EJNMMI Research. 8(1). 113–113. 16 indexed citations
11.
Bragg, Ryan A., et al.. (2016). The synthesis of tritium, carbon‐14 and stable isotope labelled selective estrogen receptor degraders. Journal of Labelled Compounds and Radiopharmaceuticals. 59(11). 454–461. 4 indexed citations
12.
Hickey, Michael J., et al.. (2016). Syntheses of a radiolabelled CXCR2 antagonist AZD5069 and its major human metabolite. Journal of Labelled Compounds and Radiopharmaceuticals. 59(11). 432–438. 1 indexed citations
13.
Kingston, Lee, et al.. (2014). A short expedient synthesis of [14C]Ticlopidine. Journal of Labelled Compounds and Radiopharmaceuticals. 57(3). 172–174. 2 indexed citations
14.
Kingston, Lee, et al.. (2010). Metal‐catalysed isotopic exchange labelling: 30 years of experience in pharmaceutical R&D. Journal of Labelled Compounds and Radiopharmaceuticals. 53(11-12). 731–738. 83 indexed citations
15.
Kingston, Lee, et al.. (2007). Use of simple stable labelled intermediates to produce complex isotopically labelled internal standards. Journal of Labelled Compounds and Radiopharmaceuticals. 50(5-6). 590–592. 1 indexed citations
16.
Jones, John R., et al.. (2005). One-step exchange-labelling of piperidines, piperazines and dialkylamines with deuterium oxide: catalysis by various ruthenium complexes. Tetrahedron Letters. 46(25). 4291–4293. 29 indexed citations
17.
19.
Kingston, Lee, et al.. (2003). Hydrogen Isotope Labelling: Novel Applications of Parallel Chemistry Techniques. ChemInform. 34(5). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026